Datasets:

electricsheepafrica
/

diabetes-hypertension-ncd

id int64	age_years int64	sex string	education string	residence string	bmi float64	bmi_category string	waist_circumference_cm float64	family_history_diabetes int64	family_history_hypertension int64	smoking_status string	alcohol_use string	physical_activity string	salt_intake_high int64	has_diabetes int64	has_hypertension int64	dual_diagnosis int64	diabetes_type string	diabetes_duration_years int64	hypertension_grade string	hypertension_duration_years int64	newly_diagnosed_dm int64	newly_diagnosed_htn int64	systolic_bp int64	diastolic_bp int64	bp_controlled int64	fasting_glucose_mmol float64	hba1c_percent int64	random_glucose_mmol float64	glycaemic_control int64	total_cholesterol int64	ldl int64	hiv_positive int64	retinopathy int64	nephropathy int64	neuropathy int64	diabetic_foot int64	cardiovascular_disease int64	stroke_history int64	heart_failure int64	ckd int64	on_antihypertensive int64	antihypertensive_class string	antihypertensive_combination int64	on_oral_hypoglycaemic int64	oral_hypoglycaemic_type string	on_statin int64	on_aspirin int64	medication_adherence string	lifestyle_counselling int64	diet_counselling int64	hospitalised_past_year int64	emergency_visit_past_year int64
1	69	F	secondary	urban	20.5	normal	77	0	1	never	none	high	0	0	1	0	none	0	grade_1	0	0	0	153	113	0	5.1	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	1	ace_inhibitor_arb	1	0	none	0	0	poor	0	0	0	0
2	51	M	secondary	urban	25.4	overweight	77	1	0	never	moderate	moderate	1	1	0	0	type_2	1	none	0	1	0	122	80	1	10.3	-1	14.4	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
3	68	F	primary	urban	24.7	normal	93	0	0	never	none	low	1	0	1	0	none	0	grade_2	7	0	1	170	114	0	4.9	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
4	53	M	primary	peri_urban	16	underweight	60	1	0	current	moderate	low	0	0	1	0	none	0	grade_1	2	0	0	141	116	0	3.8	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
5	46	M	primary	urban	32.8	obese	109	1	1	never	none	high	0	1	1	1	type_2	0	grade_3	4	1	0	214	158	0	11.7	-1	8.1	0	-1	-1	0	0	0	0	0	1	0	0	1	1	ace_inhibitor_arb	0	0	none	0	0	poor	0	1	0	1
6	25	F	primary	rural	29.2	overweight	84	0	1	never	none	high	1	1	1	1	type_2	4	grade_2	5	1	1	180	124	0	8.4	-1	18.5	0	-1	-1	0	0	0	0	0	1	0	0	1	0	none	0	0	none	0	0	not_applicable	1	1	0	0
7	82	M	none	urban	26.5	overweight	94	1	0	never	moderate	sedentary	0	1	1	1	type_2	1	grade_1	1	1	1	155	118	0	15.3	-1	12.2	0	-1	-1	0	1	0	0	0	1	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	1	1
8	67	F	primary	peri_urban	19.7	normal	69	0	0	never	heavy	low	1	1	1	1	type_2	8	grade_1	0	1	0	162	108	0	9	-1	16.9	0	-1	-1	0	1	1	1	1	1	0	1	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
9	23	M	primary	peri_urban	25.9	overweight	79	0	0	never	moderate	sedentary	0	1	0	0	type_2	11	none	0	1	0	123	75	1	8.8	-1	12.5	0	-1	-1	0	0	0	1	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	1	0	0
10	47	M	primary	urban	20.7	normal	73	0	0	never	none	low	0	0	1	0	none	0	grade_2	2	0	1	150	118	0	5	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
11	66	F	secondary	rural	25.2	overweight	73	1	0	never	moderate	moderate	0	1	1	1	type_2	11	grade_2	9	1	0	150	124	0	11.5	-1	17.2	0	-1	-1	0	0	0	0	0	0	0	0	1	1	beta_blocker	0	0	none	0	0	moderate	0	0	0	0
12	83	F	secondary	urban	33.6	obese	111	0	1	current	moderate	sedentary	0	1	1	1	type_2	2	grade_3	13	1	1	191	131	0	11.1	-1	5.9	0	-1	-1	0	0	0	0	0	0	0	0	1	0	none	0	0	none	0	0	not_applicable	0	1	0	1
13	42	M	tertiary	rural	22.7	normal	79	1	0	current	none	moderate	1	0	1	0	none	0	grade_2	9	0	0	155	125	0	5.3	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
14	27	F	none	rural	16	underweight	76	1	1	former	none	moderate	0	1	1	1	type_2	2	grade_2	1	1	1	169	118	0	11.4	-1	22.8	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
15	58	M	secondary	urban	21.2	normal	81	0	0	never	none	moderate	0	0	1	0	none	0	grade_1	6	0	1	145	115	0	5.2	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	1	0	0
16	60	M	primary	urban	24.5	normal	93	0	1	current	heavy	low	1	0	1	0	none	0	grade_1	12	0	1	149	107	0	5.6	-1	-1	0	-1	-1	0	0	0	0	0	0	0	1	0	0	none	0	0	none	0	0	not_applicable	0	1	1	0
17	89	F	tertiary	urban	34	obese	99	1	0	never	none	sedentary	1	1	1	1	type_2	2	grade_1	1	1	1	137	94	0	6.7	-1	14.2	1	-1	-1	0	0	0	1	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
18	53	F	secondary	rural	18.8	normal	64	0	0	never	none	low	1	1	0	0	type_2	3	none	0	1	0	102	74	1	11	-1	8.5	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	1	0	0
19	72	F	secondary	rural	18.9	normal	75	0	0	never	none	sedentary	0	1	0	0	type_2	20	none	0	1	0	126	70	1	15.1	-1	9.9	0	-1	-1	0	0	0	1	0	1	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	1	1
20	66	F	none	peri_urban	21.9	normal	84	0	0	never	none	high	1	0	1	0	none	0	grade_2	1	0	1	162	107	0	5.7	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	1	0	0
21	47	F	secondary	urban	25	overweight	103	1	0	never	none	sedentary	0	0	1	0	none	0	grade_1	9	0	1	135	104	0	5.1	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
22	44	M	primary	urban	37.9	obese	115	0	0	never	none	high	0	0	1	0	none	0	grade_2	4	0	1	182	120	0	4.9	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	1	0	1
23	48	M	none	urban	25.7	overweight	97	0	1	never	none	low	1	1	1	1	type_2	0	grade_2	4	1	1	160	107	0	9.6	-1	18.6	0	-1	-1	0	0	0	0	0	0	1	0	0	0	none	0	0	none	0	1	not_applicable	1	1	0	0
24	82	M	primary	urban	17.9	underweight	60	1	0	never	moderate	sedentary	0	1	1	1	type_2	20	grade_3	4	1	1	215	149	0	14.5	-1	8.4	0	-1	-1	0	0	0	1	0	0	1	1	0	0	none	0	0	none	0	1	not_applicable	1	0	0	0
25	46	F	none	urban	21.5	normal	82	0	0	never	none	high	0	1	0	0	type_2	7	none	0	1	0	107	73	1	7	-1	6.7	0	-1	-1	0	0	0	1	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
26	73	F	secondary	rural	18.8	normal	69	0	1	never	none	low	1	0	1	0	none	0	grade_2	0	0	1	159	127	0	4.3	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
27	74	M	tertiary	rural	19.5	normal	71	1	0	never	heavy	low	0	0	1	0	none	0	grade_1	13	0	1	137	115	0	4.9	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	1	0	none	0	0	none	0	0	not_applicable	1	0	0	0
28	53	F	primary	urban	26.7	overweight	89	0	1	never	none	low	1	1	1	1	type_2	8	grade_2	2	0	0	162	115	0	9.9	-1	14.1	0	-1	-1	0	0	0	1	0	0	0	0	0	0	none	0	1	metformin	0	0	moderate	1	0	0	0
29	52	M	primary	peri_urban	24.5	normal	83	1	0	never	heavy	sedentary	1	0	1	0	none	0	grade_1	0	0	0	154	123	0	6.3	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
30	56	F	secondary	peri_urban	25.4	overweight	86	0	0	former	none	moderate	1	1	1	1	type_2	1	grade_3	3	1	1	189	123	0	11.3	-1	5	0	-1	-1	0	0	0	0	0	0	1	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	1
31	82	F	none	rural	23.7	normal	75	0	1	never	moderate	low	0	1	1	1	type_2	4	grade_2	5	1	1	150	114	0	12.9	-1	14.9	0	-1	-1	1	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
32	51	F	secondary	peri_urban	25.7	overweight	95	0	1	never	none	sedentary	1	0	1	0	none	0	grade_2	0	0	1	182	119	0	3.9	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
33	44	F	tertiary	peri_urban	25.2	overweight	85	0	0	never	moderate	sedentary	1	0	1	0	none	0	grade_1	17	0	1	135	115	0	5.8	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
34	68	F	secondary	peri_urban	18.1	underweight	86	0	1	never	moderate	low	1	0	1	0	none	0	grade_1	0	0	1	149	123	0	5.1	-1	-1	0	-1	-1	0	0	0	0	0	1	0	0	0	0	none	0	0	none	1	0	not_applicable	0	0	0	0
35	29	F	primary	rural	23	normal	67	0	1	never	moderate	low	0	0	1	0	none	0	grade_2	0	0	1	176	131	0	6.1	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
36	47	M	secondary	rural	18.2	underweight	69	1	0	never	none	low	1	1	1	1	type_2	1	grade_2	0	1	1	163	115	0	4	-1	8.5	1	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
37	39	F	none	urban	25.1	overweight	95	0	0	former	none	moderate	1	1	0	0	type_2	15	none	0	1	0	102	65	1	8.5	-1	11.7	0	-1	-1	0	0	0	0	0	1	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
38	48	M	secondary	urban	30.3	obese	88	1	1	never	heavy	moderate	1	1	1	1	type_2	2	grade_3	0	0	1	170	112	0	15.9	-1	7.7	0	-1	-1	0	0	0	0	0	0	0	1	0	0	none	0	1	glibenclamide	0	0	poor	0	1	1	1
39	66	F	secondary	rural	27.1	overweight	97	1	0	never	heavy	moderate	0	1	1	1	type_2	1	grade_2	9	1	1	155	114	0	12.3	-1	16.1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	1	0	0
40	46	F	secondary	rural	21.4	normal	72	0	0	never	none	moderate	1	1	1	1	type_2	8	grade_1	3	1	1	150	124	0	15.8	-1	11.1	0	-1	-1	0	0	1	1	0	0	1	0	0	0	none	0	0	none	0	0	not_applicable	0	1	0	0
41	58	M	secondary	urban	23.8	normal	79	0	0	former	heavy	high	1	1	0	0	type_2	3	none	0	1	0	129	72	1	4	-1	8	1	-1	-1	0	0	0	1	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
42	58	F	primary	rural	24.9	normal	69	1	0	never	none	sedentary	1	1	1	1	type_2	14	grade_1	4	1	0	151	134	0	9.1	-1	9	0	-1	-1	0	1	0	0	0	1	0	0	0	1	beta_blocker	0	0	none	1	1	poor	1	0	0	0
43	55	M	none	rural	28.3	overweight	88	0	0	never	heavy	moderate	0	0	1	0	none	0	grade_1	13	0	1	146	113	0	6.4	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	1	0	0
44	22	F	primary	rural	32.4	obese	94	1	1	former	none	low	0	0	1	0	none	0	grade_1	0	0	0	139	114	0	5.4	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	1	0	0
45	23	M	tertiary	urban	24.9	normal	83	1	1	never	moderate	low	1	0	1	0	none	0	grade_3	0	0	0	170	121	0	5.1	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	1	ccb	1	0	none	0	0	poor	1	0	0	0
46	48	F	secondary	urban	29.5	overweight	93	0	0	never	heavy	moderate	1	0	1	0	none	0	grade_3	2	0	1	199	129	0	4.2	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
47	38	F	primary	urban	29.2	overweight	99	0	0	never	none	low	0	1	1	1	type_2	2	grade_1	7	1	0	133	109	0	5.4	-1	16.6	1	-1	-1	0	0	0	0	0	0	0	0	0	1	ace_inhibitor_arb	1	0	none	0	0	moderate	1	0	0	0
48	31	F	tertiary	peri_urban	23.4	normal	62	0	0	current	heavy	moderate	0	1	1	1	type_2	15	grade_2	2	1	1	151	128	0	6.2	-1	16.7	1	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
49	33	M	none	rural	22.2	normal	66	0	1	never	moderate	low	0	1	1	1	type_2	3	grade_1	1	1	0	152	100	0	10.1	-1	11.9	0	-1	-1	0	0	0	0	1	0	0	1	0	1	thiazide	1	0	none	0	0	moderate	0	0	1	1
50	47	F	tertiary	peri_urban	21.4	normal	82	0	0	former	none	moderate	0	1	1	1	type_2	1	grade_1	3	0	1	142	106	0	11.2	-1	11.7	0	-1	-1	0	0	0	0	0	0	0	1	1	0	none	0	0	none	0	0	not_applicable	0	1	0	0
51	78	M	none	rural	17.9	underweight	62	0	1	never	heavy	moderate	1	0	1	0	none	0	grade_2	0	0	1	159	120	0	4	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	1	0	0
52	72	F	secondary	urban	28.9	overweight	75	0	0	former	none	moderate	0	0	1	0	none	0	grade_1	45	0	1	138	107	0	3.9	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
53	23	F	secondary	peri_urban	21.8	normal	85	0	1	never	heavy	sedentary	0	1	1	1	type_2	5	grade_1	1	1	0	130	107	0	5.5	-1	10.5	1	-1	-1	0	0	0	0	0	0	0	0	0	1	ccb	1	0	none	0	0	poor	0	0	0	0
54	48	M	primary	urban	19	normal	66	0	1	never	moderate	moderate	0	0	1	0	none	0	grade_2	4	0	1	158	122	0	4.1	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	1	0	0
55	69	M	secondary	urban	30.5	obese	88	0	1	never	none	moderate	0	1	1	1	type_2	1	grade_2	20	1	0	152	112	0	5.1	-1	17.2	1	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
56	72	F	none	peri_urban	16	underweight	60	0	0	former	none	sedentary	1	1	1	1	type_2	3	grade_2	3	0	1	163	112	0	8.2	-1	12.8	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	1	0	0
57	40	F	tertiary	rural	27.4	overweight	87	0	0	never	none	moderate	1	0	1	0	none	0	grade_3	15	0	0	170	122	0	5.7	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	1	ace_inhibitor_arb	1	0	none	0	0	poor	0	1	0	0
58	63	F	none	urban	23.8	normal	85	0	1	never	moderate	sedentary	0	1	1	1	type_2	6	grade_1	0	1	1	146	109	0	12.7	-1	11.1	0	-1	-1	0	1	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	1	0	0
59	19	F	none	peri_urban	26.3	overweight	77	0	0	never	none	low	0	1	1	1	type_2	3	grade_1	0	1	1	155	119	0	9.5	-1	16.1	0	-1	-1	0	1	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
60	50	F	primary	rural	19.5	normal	84	0	0	never	none	high	0	1	1	1	type_2	0	grade_2	8	1	0	184	124	0	5.4	-1	9.6	1	-1	-1	0	0	0	0	0	0	0	0	0	1	ccb	0	0	none	0	0	moderate	1	0	0	0
61	60	F	secondary	urban	27.8	overweight	84	1	1	never	none	low	1	1	1	1	type_2	1	grade_1	1	1	1	152	98	0	10.9	-1	20.9	0	-1	-1	0	0	0	0	0	0	1	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
62	81	M	secondary	rural	26	overweight	90	0	0	former	none	low	0	1	1	1	type_2	8	grade_1	13	1	1	132	120	0	12.6	-1	12.9	0	-1	-1	0	1	0	1	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
63	46	F	primary	peri_urban	31.5	obese	93	0	1	never	none	moderate	1	0	1	0	none	0	grade_1	3	0	1	137	96	0	4.4	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	1	0	none	0	0	none	0	0	not_applicable	0	1	0	0
64	34	F	none	rural	22.5	normal	62	0	0	former	none	sedentary	0	0	1	0	none	0	grade_2	0	0	1	162	113	0	4.1	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
65	50	M	none	urban	26.8	overweight	99	0	0	never	none	moderate	0	1	0	0	type_2	3	none	0	1	0	130	68	1	4	-1	20.7	1	-1	-1	0	1	0	1	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
66	21	M	primary	urban	24.7	normal	85	0	0	never	none	low	1	1	1	1	type_1	6	grade_2	4	1	0	193	124	0	11.3	-1	9	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
67	24	M	secondary	urban	20.6	normal	78	1	1	never	moderate	low	1	1	0	0	type_2	4	none	0	1	0	127	84	1	21.3	-1	5	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	1	0	0
68	52	F	none	rural	16.3	underweight	68	1	1	never	none	low	1	1	1	1	type_2	3	grade_1	2	1	1	136	103	0	9.3	-1	13.5	0	-1	-1	0	0	0	0	0	1	0	0	0	0	none	0	0	none	0	1	not_applicable	0	1	0	0
69	46	F	secondary	peri_urban	25.4	overweight	78	0	1	never	none	high	0	0	1	0	none	0	grade_1	14	0	0	134	106	0	5.1	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	1	ace_inhibitor_arb	1	0	none	0	0	poor	1	1	0	0
70	70	F	secondary	peri_urban	16	underweight	77	0	0	never	moderate	high	0	1	1	1	type_2	3	grade_1	6	0	1	130	101	0	11.7	-1	7.5	0	-1	-1	0	1	0	0	0	1	0	0	0	0	none	0	1	metformin_glibenclamide	1	0	poor	0	0	0	0
71	21	M	secondary	urban	31.8	obese	108	0	0	never	none	sedentary	0	1	1	1	type_2	2	grade_2	10	1	0	174	123	0	15.5	-1	13.3	0	-1	-1	0	0	0	0	0	0	0	0	0	1	ccb	1	0	none	0	0	poor	0	1	0	0
72	62	M	primary	urban	23.5	normal	83	0	1	never	none	moderate	0	1	1	1	type_2	3	grade_3	2	0	0	196	133	0	12.5	-1	12.8	0	-1	-1	0	0	0	0	0	0	0	0	0	1	ccb	0	1	metformin	0	0	moderate	1	0	0	1
73	41	M	tertiary	rural	26.5	overweight	81	0	0	current	moderate	moderate	1	0	1	0	none	0	grade_2	8	0	1	150	118	0	3.9	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
74	71	F	secondary	rural	20.7	normal	60	0	0	current	moderate	sedentary	0	1	1	1	type_2	8	grade_2	4	1	1	150	97	0	8.9	-1	20.7	0	-1	-1	1	1	0	0	0	0	0	1	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
75	68	F	tertiary	peri_urban	30	obese	94	0	0	never	none	moderate	0	1	1	1	type_2	13	grade_3	2	0	1	172	116	0	10.4	-1	18	0	-1	-1	0	1	1	1	0	1	0	0	1	0	none	0	1	glibenclamide	0	0	good	0	0	0	0
76	61	F	secondary	rural	23.6	normal	100	0	0	never	none	low	0	1	1	1	type_2	1	grade_2	1	1	0	174	114	0	14.4	-1	24.1	0	-1	-1	0	0	0	0	1	0	0	1	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
77	52	M	secondary	rural	24.6	normal	78	0	0	never	moderate	moderate	0	1	0	0	type_2	0	none	0	1	0	142	80	0	9.7	-1	11.1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	1	0	0
78	45	F	tertiary	peri_urban	23.4	normal	90	0	1	never	moderate	sedentary	0	1	1	1	type_2	15	grade_2	15	0	1	175	132	0	16	-1	14.8	0	-1	-1	0	0	1	0	0	0	0	0	0	0	none	0	1	metformin	0	0	poor	0	0	0	0
79	54	F	primary	rural	24.6	normal	88	0	1	current	moderate	moderate	0	1	0	0	type_2	12	none	0	1	0	110	84	1	11.1	-1	5	0	-1	-1	0	1	0	1	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
80	48	F	primary	urban	17.7	underweight	64	0	0	current	moderate	low	0	0	1	0	none	0	grade_2	1	0	1	182	117	0	5.2	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	1	0	0
81	29	F	secondary	peri_urban	24.6	normal	75	0	0	current	none	sedentary	0	0	1	0	none	0	grade_1	0	0	1	136	107	0	4.7	-1	-1	0	-1	-1	1	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	1	0	0
82	65	F	none	urban	25.6	overweight	86	0	0	never	none	low	1	0	1	0	none	0	grade_2	0	0	1	179	120	0	6	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	1	0	none	0	0	none	0	0	not_applicable	1	0	0	0
83	61	F	secondary	rural	29.8	overweight	100	0	0	current	none	low	1	0	1	0	none	0	grade_2	4	0	1	168	117	0	5.2	-1	-1	0	-1	-1	1	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	1	0	0
84	31	M	secondary	urban	17.3	underweight	71	0	0	former	none	moderate	1	0	1	0	none	0	grade_2	9	0	1	153	111	0	7.2	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
85	43	M	tertiary	rural	26	overweight	83	0	1	never	none	high	1	0	1	0	none	0	grade_3	9	0	1	198	124	0	4.6	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	0	0	0
86	32	M	none	rural	26.3	overweight	77	1	1	never	none	sedentary	0	1	1	1	type_2	8	grade_3	3	1	1	177	130	0	12.7	-1	15.8	0	-1	-1	0	0	1	0	0	0	0	0	1	0	none	0	0	none	0	0	not_applicable	0	0	0	0
87	23	M	primary	urban	23.9	normal	77	1	1	never	none	low	0	1	1	1	type_2	1	grade_1	3	1	1	130	125	0	6.3	-1	17.9	1	-1	-1	0	0	0	0	0	1	0	0	0	0	none	0	0	none	0	1	not_applicable	0	0	0	0
88	33	F	secondary	peri_urban	24.2	normal	98	0	1	never	heavy	sedentary	1	0	1	0	none	0	grade_2	4	0	1	201	121	0	4.2	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	1	0	1
89	19	M	tertiary	urban	28	overweight	94	0	0	former	heavy	sedentary	0	1	0	0	type_2	1	none	0	0	0	118	69	1	7.4	-1	6.9	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	1	metformin_glibenclamide	0	0	moderate	0	0	0	0
90	74	F	tertiary	peri_urban	26.8	overweight	108	0	1	never	none	low	1	0	1	0	none	0	grade_3	2	0	1	189	115	0	5	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	1
91	69	M	none	rural	22.5	normal	79	0	0	never	moderate	high	1	1	1	1	type_2	11	grade_2	2	1	1	166	119	0	17.8	-1	6.7	0	-1	-1	0	0	1	1	0	0	0	0	1	0	none	0	0	none	0	0	not_applicable	1	0	0	0
92	83	F	primary	rural	18.3	underweight	64	0	0	never	heavy	sedentary	0	0	1	0	none	0	grade_2	4	0	0	184	126	0	6.3	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	1	ace_inhibitor_arb	0	0	none	0	0	moderate	1	0	0	0
93	61	F	primary	peri_urban	30.3	obese	93	1	1	never	moderate	moderate	1	1	1	1	type_2	1	grade_3	7	1	1	170	131	0	11.6	-1	9.2	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
94	43	F	primary	urban	22.8	normal	80	0	0	never	moderate	low	1	1	1	1	type_2	1	grade_2	3	0	1	164	113	0	5.4	-1	10.8	1	-1	-1	0	0	1	0	0	0	1	0	0	0	none	0	1	metformin	0	0	good	0	0	0	0
95	61	F	primary	urban	18.4	underweight	60	1	1	never	none	sedentary	0	1	0	0	type_2	3	none	0	0	0	131	84	1	7.3	-1	17.7	0	-1	-1	0	1	0	0	0	0	0	0	1	0	none	0	0	none	0	0	not_applicable	1	1	0	0
96	55	F	primary	peri_urban	20.9	normal	79	1	0	current	none	low	1	1	1	1	type_2	8	grade_2	7	1	0	167	122	0	9.8	-1	15.1	0	-1	-1	0	0	0	0	1	1	0	0	0	0	none	0	0	none	0	0	not_applicable	1	0	0	0
97	27	M	primary	rural	23.4	normal	100	1	0	never	none	moderate	0	1	1	1	type_2	0	grade_1	3	1	1	151	107	0	11.4	-1	8.6	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	0	1	0	0
98	49	M	tertiary	urban	22.4	normal	85	1	1	never	none	low	1	1	1	1	type_2	0	grade_3	0	1	1	181	131	0	8.3	-1	10.1	0	-1	-1	0	0	0	0	0	1	0	0	0	0	none	0	0	none	0	0	not_applicable	0	1	0	1
99	70	F	secondary	rural	25.4	overweight	69	0	1	former	none	low	0	0	1	0	none	0	grade_1	0	0	1	134	113	0	4.8	-1	-1	0	-1	-1	0	0	0	0	0	0	0	0	0	0	none	0	0	none	0	0	not_applicable	1	1	0	0
100	53	M	primary	rural	19.8	normal	61	0	0	current	none	sedentary	0	1	1	1	type_2	1	grade_1	1	1	1	134	109	0	16.4	-1	10.5	0	-1	-1	0	0	0	0	0	0	0	0	1	0	none	0	0	none	0	0	not_applicable	1	1	0	0

End of preview. Expand in Data Studio

Diabetes & Hypertension Dual Burden Dataset

Abstract

This dataset provides 30,000 simulated records (10,000 per scenario) of adults with diabetes and/or hypertension attending health facilities in sub-Saharan Africa. Each record contains 55+ variables including demographics, BMI, risk factors, BP and glucose measurements, HbA1c, complications (retinopathy, nephropathy, CVD, stroke), treatment (antihypertensives, oral hypoglycaemics, insulin), medication adherence, and control status. Three settings: urban NCD clinic, district PHC, and rural outreach.

1. Introduction

SSA has 24 million adults with diabetes, 54% undiagnosed (IDF 2021). Hypertension prevalence is 30.8% with only 7% achieving BP control (Noubiap et al., J Hypertens 2019). HbA1c availability is <5% in many SSA countries and insulin access ranges 10–60% (Pastakia et al., Lancet Diabetes Endocrinol 2017). The dual burden of diabetes and hypertension accelerates cardiovascular complications.

This dataset is entirely simulated. It must not be used for clinical decision-making.

2. Methodology

2.1 Parameterization

Parameter	Value	Source
Diabetes prevalence (SSA)	4.5% (pop), higher in clinic	IDF 2021
Undiagnosed diabetes	54%	IDF 2021
HTN prevalence (SSA)	30.8%	Noubiap et al., J Hypertens 2019
HTN awareness / treatment / control	27% / 18% / 7%	Ataklte et al., 2015
Diabetic retinopathy (SSA)	31–52%	Asmelash & Asmelash, 2019
Insulin access	10–60%	Pastakia et al., 2017

2.2 Scenario Design

Scenario	Setting	HbA1c	Insulin Access	BP Control	Newly Diagnosed
Urban NCD clinic	Tertiary NCD clinic	Yes	60%	7%	37–51%
District PHC	District health centre	No	25%	6%	40–69%
Rural outreach	Rural screening	No	10%	4%	31–83%

3. Schema

Column	Type	Description
id	int	Unique identifier
age_years	int	Patient age
sex	categorical	M / F
education	categorical	none / primary / secondary / tertiary
residence	categorical	urban / peri_urban / rural
bmi	float	Body mass index
bmi_category	categorical	underweight / normal / overweight / obese
waist_circumference_cm	float	Waist circumference
family_history_diabetes	binary	Family history of DM
family_history_hypertension	binary	Family history of HTN
smoking_status	categorical	never / current / former
alcohol_use	categorical	none / moderate / heavy
physical_activity	categorical	sedentary / low / moderate / high
salt_intake_high	binary	High salt intake
has_diabetes	binary	Diabetes diagnosis
has_hypertension	binary	Hypertension diagnosis
dual_diagnosis	binary	Both DM and HTN
diabetes_type	categorical	type_1 / type_2 / none
diabetes_duration_years	int	Years since DM diagnosis
hypertension_grade	categorical	grade_1 / grade_2 / grade_3 / none
hypertension_duration_years	int	Years since HTN diagnosis
newly_diagnosed_dm	binary	Previously undiagnosed DM
newly_diagnosed_htn	binary	Previously undiagnosed HTN
systolic_bp	int	Systolic blood pressure
diastolic_bp	int	Diastolic blood pressure
bp_controlled	binary	BP <140/90
fasting_glucose_mmol	float	Fasting glucose (-1 if not done)
hba1c_percent	float	HbA1c (-1 if not done)
random_glucose_mmol	float	Random glucose (-1 if not done)
glycaemic_control	binary	HbA1c <7% or FG <7 mmol/L
total_cholesterol	float	Total cholesterol (-1 if not done)
ldl	float	LDL cholesterol (-1 if not done)
hiv_positive	binary	HIV status
retinopathy	binary	Diabetic retinopathy
nephropathy	binary	Diabetic nephropathy
neuropathy	binary	Diabetic neuropathy
diabetic_foot	binary	Diabetic foot complications
cardiovascular_disease	binary	CVD
stroke_history	binary	Previous stroke
heart_failure	binary	Heart failure
ckd	binary	Chronic kidney disease
on_antihypertensive	binary	On antihypertensive
antihypertensive_class	categorical	ACEi/ARB / CCB / thiazide / beta_blocker
antihypertensive_combination	binary	Combination therapy
on_oral_hypoglycaemic	binary	On oral hypoglycaemic
oral_hypoglycaemic_type	categorical	metformin / glibenclamide / combination
on_insulin	binary	On insulin
on_statin	binary	On statin
on_aspirin	binary	On aspirin
medication_adherence	categorical	good / moderate / poor / not_applicable
lifestyle_counselling	binary	Received lifestyle counselling
diet_counselling	binary	Received diet counselling
hospitalised_past_year	binary	Hospitalised in past year
emergency_visit_past_year	binary	Emergency visit in past year

4. Validation

Validation Report

Key validation checks:

BP control: 7% urban → 6% district → 4% rural, consistent with Ataklte et al. ✓
Undiagnosed HTN: Increases from urban to rural ✓
Insulin access gradient: 60% → 25% → 10% ✓
Complications: Retinopathy, neuropathy prevalence consistent with Asmelash 2019 ✓
Medication adherence: 40% poor, reflecting SSA literature ✓

5. Usage

from datasets import load_dataset
dataset = load_dataset("electricsheepafrica/diabetes-hypertension-ncd", "district_phc")
df = dataset["train"].to_pandas()

python generate_dataset.py --all-scenarios --n 10000 --seed 42

6. Limitations

Simulated: Not derived from real NCD clinic data.
Cross-sectional: Single visit, no longitudinal treatment response.
No retinal images: Retinopathy is binary, not graded with imaging.
Simplified pharmacology: No dose titration or polypharmacy interactions.
Clinic-based prevalence: Higher than population prevalence due to selection.

7. References

IDF Diabetes Atlas 10th ed (2021). International Diabetes Federation.
Ataklte F, et al. (2015). HTN in SSA. BMC Cardiovasc Disord, 15:46.
Pastakia SD, et al. (2017). DM management in SSA. Lancet Diabetes Endocrinol, 5(8):622–667.
Noubiap JJ, et al. (2019). HTN prevalence SSA. J Hypertens, 37(5):878–889.
Price AJ, et al. (2018). NCD risk factors SSA. Lancet Glob Health, 6(9):e1010.
Asmelash D, Asmelash Y (2019). Diabetic complications in SSA. J Diabetes Res, 2019:4321058.
Kengne AP, et al. (2005). CVD complications of DM in SSA. Lancet, 366(9482):1627.
WHO (2021). HEARTS technical package for CVD management.

Citation

@dataset{esa_dm_htn_2025,
  title={Diabetes and Hypertension Dual Burden Dataset},
  author={Electric Sheep Africa},
  year={2025},
  publisher={Hugging Face},
  url={https://huggingface.co/datasets/electricsheepafrica/diabetes-hypertension-ncd}
}

License

CC-BY-4.0

Downloads last month: 58